FI 6828K
Latest Information Update: 05 Dec 2003
Price :
$50 *
At a glance
- Originator Ferrer
- Class Antihypertensives; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 05 Dec 2003 No development reported - Preclinical for Hypertension in Spain (unspecified route)
- 28 Feb 2001 New profile
- 28 Feb 2001 Preclinical development for Hypertension in Spain (Unknown route)